Selected article for: "antiviral defense and human cell"

Author: Fu, Yu; Lee, Inhan; Lee, Yong Sun; Bao, Xiaoyong
Title: Small Non-coding Transfer RNA-Derived RNA Fragments (tRFs): Their Biogenesis, Function and Implication in Human Diseases
  • Document date: 2015_12_31
  • ID: 0b08jyjs_29
    Snippet: Using an elegant biochemical approach, named HITS-ABt (hIgh-throughput sequencing of RNAs associated with biotinylated tRF), to capture tRF5-GluCTC-containing ribonucleoprotein complexes combined with bioinformatics analysis, we have identified a number of potential cellular mRNA targets of tRF5-GluCTC. One of the candidate mRNAs was shown to be a direct target of tRF5-GluCTC. Mechanistically, tRF5-GluCTC recognizes a target site in the 3ËŠ-untra.....
    Document: Using an elegant biochemical approach, named HITS-ABt (hIgh-throughput sequencing of RNAs associated with biotinylated tRF), to capture tRF5-GluCTC-containing ribonucleoprotein complexes combined with bioinformatics analysis, we have identified a number of potential cellular mRNA targets of tRF5-GluCTC. One of the candidate mRNAs was shown to be a direct target of tRF5-GluCTC. Mechanistically, tRF5-GluCTC recognizes a target site in the 3ËŠ-untranslated region of APOER2 mRNA and suppresses its expression by an unknown mechanism. Further analysis identified a previously unappreciated role for APOER2 protein in antiviral defense against RSV infection [61] . Thus, we have illuminated the roles of tRFs in host-virus interactions and described a novel molecular mechanism for host response regulation via gene targeting at posttranscriptional level, proving a potential therapeutic target to control RSV replication by regulating tRFs induction. As another example of tRFs with a positive effect on viral replication, a tRF-3 derived from tRNA Pro (tRF-3019) has been suggested to function as a primer for reverse transcrip-tion of human T-cell leukemia virus-1 [62] .

    Search related documents:
    Co phrase search for related documents
    • antiviral defense and high throughput: 1, 2, 3
    • antiviral defense and high throughput sequencing: 1
    • antiviral defense and host response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral defense and host response regulation: 1
    • antiviral defense and host virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral defense and host virus interaction: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • biochemical approach and direct target: 1
    • biochemical approach and high throughput: 1, 2
    • bioinformatic analysis and direct target: 1, 2
    • bioinformatic analysis and high throughput: 1, 2, 3, 4, 5, 6, 7
    • bioinformatic analysis and high throughput sequencing: 1, 2, 3, 4
    • bioinformatic analysis and host response: 1, 2, 3, 4, 5
    • bioinformatic analysis and host virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • direct target and high throughput: 1, 2, 3, 4, 5
    • direct target and high throughput sequencing: 1
    • direct target and host response: 1
    • direct target and host virus: 1, 2, 3, 4, 5, 6
    • expression suppress and high throughput: 1
    • expression suppress and host response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11